Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation-Reference-Cited by-同舟云学术

Bortezomib and fenretinide induce synergistic cytotoxicity in mantle cell lymphoma through apoptosis, cell-cycle dysregulation, and IκBα kinase downregulation

Published:2015-10 Issue:9 Volume:26 Page:974-983
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Cowan Andrew J.,Frayo Shani L.,Press Oliver W.,Palanca-Wessels Maria C.,Pagel John M.,Green Damian J.,Gopal Ajay K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference47 articles.

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkins lymphoma. The Non-Hodgkins Lymphoma Classification Project.;Blood,1997

2. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.;Vose;Am J Hematol,2013

3. . Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.;Zhou;Cancer,2008

4. Expression of cyclins D-type in B-chronic lymphoproliferative disorders.;Sola;Leukemia,2000

5. How I manage mantle cell lymphoma.;Dreyling;Leukemia,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL;Blood Advances;2023-03-01

2. A Lipid-Based In Situ-Forming Hexagonal Phase for Prolonged Retention and Drug Release in the Breast Tissue;AAPS PharmSciTech;2022-09-19

3. Sphingolipids and Lymphomas: A Double-Edged Sword;Cancers;2022-04-19

4. Microemulsion for Prolonged Release of Fenretinide in the Mammary Tissue and Prevention of Breast Cancer Development;Molecular Pharmaceutics;2021-08-17

5. Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells;Frontiers in Oncology;2021-06-15